First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia

Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Rep
Hauptverfasser: Ahmed, Zarir, Davaro, Elizabeth, Batanian, Jacqueline, Verma, Nilesh
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2019
Schlagworte:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536188/
https://ncbi.nlm.nih.gov/pubmed/31101747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228149
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge